Few properties influence a pharmaceutical product’s behavior as decisively as particle size. It governs dissolution rate and bioavailability, drives powder flow and blend uniformity, determines whether an inhaled or nasal dose reaches its intended site of deposition, and can make the difference between a stable nanoparticle formulation and one that aggregates on the shelf. Yet particle size is not one measurement, it is a family of questions, each demanding a different technique, and few laboratories in Europe can answer as many of them, at this level of rigor, in one place. This is the ground Alfatestlab has built its identity on.

Alfatestlab’s story begins with Alfatest, an Italian company that has spent decades distributing some of the world’s leading manufacturers of particle characterization instrumentation, Malvern Panalytical among them. That long commercial relationship translated, over time, into something rarer than distribution: a deep, hands-on understanding of what each technology can and cannot see, where its blind spots lie, and how its results compare with those of neighboring techniques. Alfatestlab was created as the natural extension of that expertise, a contract laboratory built around the same instrumentation Alfatest has represented for years, now put to work for pharmaceutical, biotech and healthcare clients who need answers, not just data.

This lineage matters more than it might first appear. A laboratory that has only ever operated an instrument as an end user tends to trust its output at face value; one that has spent decades installing, servicing and training clients on that same instrument develops a sharper sense of its limitations and the sample preparation choices that can make or break a result. That is the perspective Alfatestlab brings to every study it runs.

Particle size sits at the center of pharmaceutical development for reasons regulators take seriously. ICH Q6A and the corresponding Ph. Eur. and USP chapters treat particle size distribution as a critical quality attribute for a wide range of dosage forms, from oral solids to inhalation and injectable products. A subtle shift in distribution can alter dissolution behavior, content uniformity, or aerodynamic performance, which is why the choice of technique, or combination of techniques, is rarely a formality.

A core part of Alfatestlab’s offering is performed under GMP: laser diffraction, Morphologically-Directed Raman Spectroscopy (MDRS) and Dynamic Light Scattering (DLS) are all available as GMP-certified services, alongside the ISO 17025-accredited scope. Laser diffraction, run on Malvern Panalytical’s Mastersizer 3000, covers powders and liquid dispersions across a wide size range, while the companion Spraytec system extends the same principle to sprays and aerosols. For nasal and inhaled products, the laboratory also operates dedicated dose actuators: a Proveris Vereo and an Innova Systems actuator, firing doses under controlled, reproducible conditions ahead of spray characterization.

Laser diffraction delivers fast, reproducible bulk distributions and is often the first technique of choice for routine powder and liquid dispersion analysis. For particles that depart from a spherical shape such as needle-shaped crystals, agglomerates, fibrous materials, or for formulations where one chemical species needs to be distinguished from another within the same mixture, Alfatestlab complements it with Morphologically-Directed Raman Spectroscopy (MDRS), one of its most distinctive GMP capabilities. By combining automated image analysis with Raman spectroscopy, MDRS captures the true size and shape of individual particles and chemically identifies representative particles within each morphological group. The practical consequence is significant: in a powder blend or suspension containing an active ingredient dispersed among one or more excipients, MDRS can isolate and report the particle size distribution of the API alone, separately from the rest of the formulation, a level of resolution that laser diffraction, which reports on the bulk population as a whole, is not designed to provide. This works equally well on dry powder blends and on wet dispersions such as creams and suspensions, making it uniquely useful wherever knowing “how big are the API particles, specifically” matters more than the average size of everything in the sample.

Alongside these techniques, Alfatestlab’s broader platform extends into complementary static and dynamic image analysis to assess particle size and shape through direct imaging, offering a further cross-check on morphology. On the nanoscale, dynamic light scattering and zeta potential sit alongside Nanoparticle Tracking Analysis (NTA), which tracks individual particles under Brownian motion for high-resolution, particle-by-particle distributions, increasingly requested for lipid nanoparticles (LNPs) and other nanosystems used in advanced and gene-based therapies.

Scanning electron microscopy (SEM) is complemented by Energy-dispersive X-ray (EDX) analysis to add elemental composition mapping on top of the image, turning visual inspection into chemical identification, particularly valuable for investigating foreign particle contamination, where identifying an unexpected particle’s elemental composition is often the key to tracing its origin.

This complementarity is where the real value of the platform lies: the ability to cross-validate a result to confirm what laser diffraction suggests about a powder’s bulk distribution with what MDRS reveals about individual particle shape and chemical identity, or to complement a nanosuspension’s DLS measurement with NTA’s particle-level resolution. For a formulation scientist troubleshooting a dissolution result, a regulatory team building a physicochemical equivalence dossier, or a quality team investigating a foreign particle deviation, this cross-technique fluency often separates a data point from a real explanation: the kind of judgement that comes from years of working with these instruments across hundreds of client projects, not from operating any one in isolation.

It is worth underlining what makes this offering genuinely uncommon in Europe: having laser diffraction, MDRS and dynamic light scattering available under GMP, complemented by dynamic and static image analysis, NTA and electron microscopy with EDX for the applications that need them, within a single GMP-authorized facility, is not a common proposition. Many laboratories offer a subset of these techniques; fewer can move a sample from bulk powder characterization to nanoparticle-level analysis without changing supplier.

For pharmaceutical companies developing solid oral dosage forms, topical and inhaled products, or nanoparticle-based therapies, Alfatestlab’s proposition is straightforward: one partner, one team, and a genuinely complete view of particle size and morphology, built on decades of instrument expertise and grounded in GMP rigor.

Find out more about Alfatestlab’s particle characterization services at www.alfatestlab.com or contact us at info@alfatestlab.com